ELV vs HUM — Key Metrics

Metric ELV (ELEVANCE HEALTH INC) HUM (HUMANA INC)
Price400.84385.78
Market Cap86.6 Billion46.33 Billion
P/E (TTM)16.9737.17
P/B (Quarterly)2.0992.767
P/S (TTM)0.430.3
Net Profit Margin (TTM)2.50.8
Gross Margin (TTM)15.513.0
ROE (TTM)11.66.7
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

ELEVANCE HEALTH INC
vs
 
HUMANA INC
 
ELEVANCE HEALTH INC
vs
 
HUMANA INC
Performance Comparison
AI Model Recommendation
ELV · ELEVANCE HEALTH INC

Outperform

53
UnderperformOutperform
HUM · HUMANA INC

Outperform

33
UnderperformOutperform
Recommendation Summary

Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: ELV.

Financial Metrics
Prices delayed ~15 min
ELV Metrics HUM
$400.84 Price $385.78
— Market Capitalization —
16.97 Price to Earnings Ratio 37.17
0.43 Price to Sales 0.3
13.3 Price to FCF Ratio 14.65
2.77 Price to Gross Profit 2.31
1.26 Price to Current Assets 1.17

ELV vs HUM at a glance

Elevance Health INC (ELV) and Humana INC (HUM) are both Healthcare Plans companies in the Healthcare sector. ELV is the larger, at $86.6 billion in market value against $46.3 billion for HUM, about 1.9 times the size.

On trailing-twelve-month figures, ELV trades at 17.0 times trailing earnings and HUM at 37.2; net profit margins are 2.5% and 0.8%.

The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.